/APTA.L
APTA.L Stock - Aptamer Group plc
Healthcare|BiotechnologyLSE
$0.80+6.67%
+$0.05 (+6.67%) • Dec 22
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.67
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.92
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.88
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for APTA.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.79 – $0.81
TARGET (TP)$0.92
STOP LOSS$0.74
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.71
52W High$1.57
52W Low$0.23
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.20M | $860,000 | $1.75M | $4.04M | $1.28M |
| Gross Profit | $350,000 | $250,000 | $359,000 | $2.69M | $538,400 |
| Gross Margin | 29.1% | 29.1% | 20.5% | 66.5% | 42.1% |
| Operating Income | $-2,697,000 | $-3,084,000 | $-8,157,000 | $-2,576,000 | $-2,297,600 |
| Net Income | $-2,424,000 | $-2,958,000 | $-7,836,000 | $-2,093,000 | $-1,849,600 |
| Net Margin | -201.5% | -344.0% | -447.3% | -51.9% | -144.5% |
| EPS | $-0.00 | $-0.01 | $-0.11 | $-0.03 | $-0.03 |
Company Overview
Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom and internationally. The company's binders engineered to address issues which founds with molecules, such as antibodies; and offers solutions to bioprocessing, diagnostic, and pharmaceutical scientists. It serves pharma companies, diagnostic development companies, and research institutes. The company was incorporated in 2014 and is based in York, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
APTA.LBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q1 2025
EPS Surprise History
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q1 24
No data
Q4 24
No data
Q1 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 9, 2026 | — | — | — | — |
Q1 2025 | Mar 11, 2025 | — | $-0.00 | — | — |
Q4 2024 | Oct 22, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 28, 2024 | — | $-0.01 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.08 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.04 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.02 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.01 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.00 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.00 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-0.00 | — | — |
Q3 2018 | Sep 30, 2018 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about APTA.L
What is APTA.L's current stock price?
Aptamer Group plc (APTA.L) is currently trading at $0.80 per share. The stock has moved +6.67% today.
What is the analyst price target for APTA.L?
No analyst price targets are currently available for this stock.
What sector is Aptamer Group plc in?
Aptamer Group plc operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the LSE exchange.
What is APTA.L's market cap?
Aptamer Group plc has a market capitalization of $0.02 billion, making it a small-cap company.
Does APTA.L pay dividends?
No, Aptamer Group plc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAREC.L
Arecor Therapeutics plc
$80.50
Mkt Cap: $3.0B
FAB.L
Fusion Antibodies plc
$13.00
Mkt Cap: $1.5B
FUM.L
Futura Medical plc
$1.08
Mkt Cap: $0.3B
GENF.L
Genflow Biosciences plc
$1.80
Mkt Cap: $0.9B
IHC.L
Inspiration Healthcare Group plc
$15.25
Mkt Cap: $1.4B
NCYT.L
Novacyt S.A.
$37.35
Mkt Cap: $2.6B
OBD.L
Oxford BioDynamics Plc
$0.23
Mkt Cap: $0.5B
POLB.L
Poolbeg Pharma PLC
$4.00
Mkt Cap: $2.8B
RENX.L
Renalytix Plc
$6.25
Mkt Cap: $2.1B
SAR.L
Sareum Holdings plc
$15.50
Mkt Cap: $2.1B
Explore stocks similar to APTA.L for comparison